

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.02368088 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.02368088 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.40955746 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.40955746 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.31398824 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.26276704 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.26276704 |
| 8 | intestinal cholesterol absorption (GO:0030299) | 4.23840779 |
| 9 | protein retention in ER lumen (GO:0006621) | 4.04638065 |
| 10 | cell adhesion mediated by integrin (GO:0033627) | 3.86424378 |
| 11 | lysine metabolic process (GO:0006553) | 3.75991837 |
| 12 | lysine catabolic process (GO:0006554) | 3.75991837 |
| 13 | COPII vesicle coating (GO:0048208) | 3.74682474 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 3.74338630 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.64726609 |
| 16 | protein carboxylation (GO:0018214) | 3.61464669 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.61464669 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 3.51897953 |
| 19 | 4-hydroxyproline metabolic process (GO:0019471) | 3.46021303 |
| 20 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.43369896 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 3.41819982 |
| 22 | glyoxylate metabolic process (GO:0046487) | 3.41468417 |
| 23 | desmosome organization (GO:0002934) | 3.40986424 |
| 24 | cysteine metabolic process (GO:0006534) | 3.40812937 |
| 25 | intestinal absorption (GO:0050892) | 3.36204590 |
| 26 | glucocorticoid biosynthetic process (GO:0006704) | 3.33495849 |
| 27 | fatty acid beta-oxidation (GO:0006635) | 3.33205495 |
| 28 | transcytosis (GO:0045056) | 3.31069220 |
| 29 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.29022643 |
| 30 | exocrine pancreas development (GO:0031017) | 3.28484632 |
| 31 | homocysteine metabolic process (GO:0050667) | 3.26163762 |
| 32 | valine metabolic process (GO:0006573) | 3.19592357 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.18071692 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 3.16902713 |
| 35 | fatty acid oxidation (GO:0019395) | 3.15438361 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 3.10921872 |
| 37 | lipid oxidation (GO:0034440) | 3.10295233 |
| 38 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.09017108 |
| 39 | reverse cholesterol transport (GO:0043691) | 3.08259237 |
| 40 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.08225108 |
| 41 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.08064697 |
| 42 | 2-oxoglutarate metabolic process (GO:0006103) | 3.07868814 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 3.06868284 |
| 44 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.04769177 |
| 45 | fatty acid catabolic process (GO:0009062) | 3.04560460 |
| 46 | negative regulation of fibrinolysis (GO:0051918) | 3.03867808 |
| 47 | kynurenine metabolic process (GO:0070189) | 3.02236669 |
| 48 | regulation of protein activation cascade (GO:2000257) | 3.00671309 |
| 49 | regulation of cholesterol homeostasis (GO:2000188) | 2.96891084 |
| 50 | cellular modified amino acid catabolic process (GO:0042219) | 2.96828487 |
| 51 | negative regulation of protein activation cascade (GO:2000258) | 2.94716209 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 2.94029115 |
| 53 | acylglycerol homeostasis (GO:0055090) | 2.92447737 |
| 54 | triglyceride homeostasis (GO:0070328) | 2.92447737 |
| 55 | bile acid biosynthetic process (GO:0006699) | 2.91101117 |
| 56 | aspartate family amino acid catabolic process (GO:0009068) | 2.89047746 |
| 57 | regulation of complement activation (GO:0030449) | 2.88619474 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 2.88599477 |
| 59 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.88380184 |
| 60 | complement activation, alternative pathway (GO:0006957) | 2.88013489 |
| 61 | negative regulation of complement activation (GO:0045916) | 2.86892947 |
| 62 | regulation of fibrinolysis (GO:0051917) | 2.85731684 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.85437178 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 2.85007762 |
| 65 | chondrocyte proliferation (GO:0035988) | 2.84915362 |
| 66 | phospholipid homeostasis (GO:0055091) | 2.83938024 |
| 67 | positive regulation of nuclease activity (GO:0032075) | 2.83286341 |
| 68 | monocarboxylic acid catabolic process (GO:0072329) | 2.81509049 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 2.80802221 |
| 70 | protein-lipid complex remodeling (GO:0034368) | 2.80802221 |
| 71 | macromolecular complex remodeling (GO:0034367) | 2.80802221 |
| 72 | fatty acid transmembrane transport (GO:1902001) | 2.79365048 |
| 73 | tricarboxylic acid metabolic process (GO:0072350) | 2.78699705 |
| 74 | macroautophagy (GO:0016236) | 2.78612683 |
| 75 | regulation of cholesterol esterification (GO:0010872) | 2.76505360 |
| 76 | hormone catabolic process (GO:0042447) | 2.75788637 |
| 77 | tryptophan metabolic process (GO:0006568) | 2.75135594 |
| 78 | carnitine metabolic process (GO:0009437) | 2.74912570 |
| 79 | phospholipid efflux (GO:0033700) | 2.74768280 |
| 80 | endocardial cushion development (GO:0003197) | 2.74236514 |
| 81 | branched-chain amino acid catabolic process (GO:0009083) | 2.74197690 |
| 82 | lipoprotein metabolic process (GO:0042157) | 2.73218274 |
| 83 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.72546850 |
| 84 | bile acid and bile salt transport (GO:0015721) | 2.71639622 |
| 85 | endocrine pancreas development (GO:0031018) | 2.71366823 |
| 86 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.71244151 |
| 87 | bile acid metabolic process (GO:0008206) | 2.70212124 |
| 88 | ketone body metabolic process (GO:1902224) | 2.69857239 |
| 89 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.67649077 |
| 90 | indole-containing compound catabolic process (GO:0042436) | 2.66980337 |
| 91 | indolalkylamine catabolic process (GO:0046218) | 2.66980337 |
| 92 | tryptophan catabolic process (GO:0006569) | 2.66980337 |
| 93 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.66859960 |
| 94 | hemidesmosome assembly (GO:0031581) | 2.66628602 |
| 95 | cellular glucuronidation (GO:0052695) | 2.66613763 |
| 96 | positive regulation of glycolytic process (GO:0045821) | 2.65607486 |
| 97 | branched-chain amino acid metabolic process (GO:0009081) | 2.64798767 |
| 98 | carnitine shuttle (GO:0006853) | 2.63834014 |
| 99 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.63683638 |
| 100 | cellular response to unfolded protein (GO:0034620) | 2.63565302 |
| 101 | ER-nucleus signaling pathway (GO:0006984) | 2.62385531 |
| 102 | drug transmembrane transport (GO:0006855) | 2.59791245 |
| 103 | positive regulation of fatty acid oxidation (GO:0046321) | 2.59677313 |
| 104 | cholesterol efflux (GO:0033344) | 2.57802105 |
| 105 | coenzyme catabolic process (GO:0009109) | 2.57801637 |
| 106 | urea cycle (GO:0000050) | 2.57741898 |
| 107 | urea metabolic process (GO:0019627) | 2.57741898 |
| 108 | tyrosine metabolic process (GO:0006570) | 2.57218040 |
| 109 | Leydig cell differentiation (GO:0033327) | 2.57085006 |
| 110 | response to lipoprotein particle (GO:0055094) | 2.56130496 |
| 111 | fibrinolysis (GO:0042730) | 2.55993718 |
| 112 | negative regulation of fatty acid transport (GO:2000192) | 2.55464222 |
| 113 | iron ion import (GO:0097286) | 2.54946222 |
| 114 | alpha-amino acid catabolic process (GO:1901606) | 2.51227456 |
| 115 | peptide hormone processing (GO:0016486) | 2.51190236 |
| 116 | cellular amino acid catabolic process (GO:0009063) | 2.51107735 |
| 117 | sterol homeostasis (GO:0055092) | 2.50932006 |
| 118 | cholesterol homeostasis (GO:0042632) | 2.50788728 |
| 119 | regulation of nuclease activity (GO:0032069) | 2.50551540 |
| 120 | collagen fibril organization (GO:0030199) | 2.50301667 |
| 121 | glucocorticoid metabolic process (GO:0008211) | 2.50077925 |
| 122 | androgen biosynthetic process (GO:0006702) | 2.49509701 |
| 123 | glomerular visceral epithelial cell development (GO:0072015) | 2.49270397 |
| 124 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.48698162 |
| 125 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.47970610 |
| 126 | embryonic foregut morphogenesis (GO:0048617) | 2.46432954 |
| 127 | progesterone metabolic process (GO:0042448) | 2.44708612 |
| 128 | keratan sulfate catabolic process (GO:0042340) | 2.43423430 |
| 129 | glomerular basement membrane development (GO:0032836) | 2.43416313 |
| 130 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.42879504 |
| 131 | skin morphogenesis (GO:0043589) | 2.42024276 |
| 132 | smooth muscle tissue development (GO:0048745) | 2.41663967 |
| 133 | response to follicle-stimulating hormone (GO:0032354) | 2.41250345 |
| 134 | substrate-dependent cell migration (GO:0006929) | 2.40966522 |
| 135 | protein hydroxylation (GO:0018126) | 2.40829239 |
| 136 | regulation of hippo signaling (GO:0035330) | 2.39737889 |
| 137 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.39636944 |
| 138 | regulation of apoptotic cell clearance (GO:2000425) | 2.39417502 |
| 139 | fibroblast migration (GO:0010761) | 2.36576164 |
| 140 | lipid translocation (GO:0034204) | 2.34518712 |
| 141 | phospholipid translocation (GO:0045332) | 2.34518712 |
| 142 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.33098508 |
| 143 | intestinal epithelial cell development (GO:0060576) | 2.33058181 |
| 144 | positive regulation of hormone metabolic process (GO:0032352) | 2.33002905 |
| 145 | negative regulation of protein localization to cell surface (GO:2000009) | 2.29546657 |
| 146 | C21-steroid hormone metabolic process (GO:0008207) | 2.29141421 |
| 147 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.28638075 |
| 148 | anterior/posterior axis specification, embryo (GO:0008595) | 2.26896948 |
| 149 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.25943224 |
| 150 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.24404427 |
| 151 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.23901670 |
| 152 | sphingosine metabolic process (GO:0006670) | 2.23303644 |
| 153 | Golgi to endosome transport (GO:0006895) | 2.23047725 |
| 154 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.22730670 |
| 155 | intracellular lipid transport (GO:0032365) | 2.22709080 |
| 156 | flavonoid metabolic process (GO:0009812) | 2.21322849 |
| 157 | endodermal cell differentiation (GO:0035987) | 2.20932897 |
| 158 | androgen metabolic process (GO:0008209) | 2.20686323 |
| 159 | glomerular epithelial cell development (GO:0072310) | 2.20490774 |
| 160 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.20391464 |
| 161 | cellular response to ethanol (GO:0071361) | 2.19997543 |
| 162 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.19683857 |
| 163 | regulation of transforming growth factor beta production (GO:0071634) | 2.19321587 |
| 164 | sphingomyelin metabolic process (GO:0006684) | 2.17982447 |
| 165 | wound healing, spreading of epidermal cells (GO:0035313) | 2.14891712 |
| 166 | extracellular regulation of signal transduction (GO:1900115) | 2.14520056 |
| 167 | extracellular negative regulation of signal transduction (GO:1900116) | 2.14520056 |
| 168 | oligosaccharide catabolic process (GO:0009313) | 2.13780052 |
| 169 | sterol transport (GO:0015918) | 2.13771508 |
| 170 | cholesterol transport (GO:0030301) | 2.13771508 |
| 171 | lung lobe morphogenesis (GO:0060463) | 2.13722209 |
| 172 | sphingoid metabolic process (GO:0046519) | 2.13673868 |
| 173 | glucuronate metabolic process (GO:0019585) | 2.12734820 |
| 174 | uronic acid metabolic process (GO:0006063) | 2.12734820 |
| 175 | endocrine hormone secretion (GO:0060986) | 2.12426619 |
| 176 | plasma lipoprotein particle assembly (GO:0034377) | 2.10763954 |
| 177 | regulation of keratinocyte proliferation (GO:0010837) | 2.09406859 |
| 178 | protein targeting to vacuole (GO:0006623) | 2.09185128 |
| 179 | protein targeting to lysosome (GO:0006622) | 2.09185128 |
| 180 | establishment of protein localization to vacuole (GO:0072666) | 2.09185128 |
| 181 | mesodermal cell differentiation (GO:0048333) | 2.08526189 |
| 182 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.07618858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.84971519 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.03276351 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.46357721 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.30194662 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.21130738 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.53825649 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.29050859 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.02391491 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.97230587 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.94687341 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.83044652 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.82328950 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56364091 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.48232020 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.38724357 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.33800329 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.32268969 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31233662 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.28949634 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.28155081 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.09768066 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.06786576 |
| 23 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.02220166 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96361318 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.91472706 |
| 26 | TP53_16413492_ChIP-PET_HCT116_Human | 1.83557868 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79957319 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.79033719 |
| 29 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.73168173 |
| 30 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.72936819 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71122463 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.69294924 |
| 33 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.67883772 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.67093887 |
| 35 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.66832090 |
| 36 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.65664990 |
| 37 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62399404 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.61776499 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.61163986 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58540605 |
| 41 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.57097901 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.56875531 |
| 43 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56580401 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55674695 |
| 45 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.54057211 |
| 46 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53982454 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.53483297 |
| 48 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53442095 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53174312 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.52865012 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.52865012 |
| 52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52575184 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51579610 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.51083014 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50701526 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50447532 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.45861867 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.44686924 |
| 59 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.43053932 |
| 60 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.43053932 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42367560 |
| 62 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.40518618 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39787582 |
| 64 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.39341397 |
| 65 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38583972 |
| 66 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37540417 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37335740 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36941295 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36548394 |
| 70 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.35781353 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35523918 |
| 72 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.35042314 |
| 73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.34697643 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33304963 |
| 75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32782650 |
| 76 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.32584767 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32350171 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32219604 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31939389 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31030120 |
| 81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30951884 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30270161 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.29974851 |
| 84 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29575449 |
| 85 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.28426633 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26903597 |
| 87 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.26656878 |
| 88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26529600 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26402564 |
| 90 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22759513 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22604046 |
| 92 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.21737517 |
| 93 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20152287 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19536047 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19296416 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17795152 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.16717660 |
| 98 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.15964886 |
| 99 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15356461 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14261596 |
| 101 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14110535 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13301166 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13185507 |
| 104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11506071 |
| 105 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11316138 |
| 106 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10874456 |
| 107 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10647785 |
| 108 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09092766 |
| 109 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07536191 |
| 110 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.07501312 |
| 111 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07500595 |
| 112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07273480 |
| 113 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06686726 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05734007 |
| 115 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05483277 |
| 116 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05211676 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.04798788 |
| 118 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03760772 |
| 119 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03760772 |
| 120 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03399946 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03239198 |
| 122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02528817 |
| 123 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01567435 |
| 124 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.01445615 |
| 125 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.95269821 |
| 126 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95010780 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92983093 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92971591 |
| 129 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92398555 |
| 130 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91427600 |
| 131 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91353428 |
| 132 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91353428 |
| 133 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91266097 |
| 134 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88910315 |
| 135 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87631426 |
| 136 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.86283112 |
| 137 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81782927 |
| 138 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.81673101 |
| 139 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79459893 |
| 140 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77655465 |
| 141 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.77312125 |
| 142 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76986680 |
| 143 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74343331 |
| 144 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.74129007 |
| 145 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71989192 |
| 146 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.71081565 |
| 147 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.70669361 |
| 148 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.70122351 |
| 149 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.69717597 |
| 150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68692687 |
| 151 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66328272 |
| 152 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.65788994 |
| 153 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.65522326 |
| 154 | RXR_22108803_ChIP-Seq_LS180_Human | 0.64874443 |
| 155 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.64078408 |
| 156 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.63937558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.90752611 |
| 2 | MP0005360_urolithiasis | 4.07344434 |
| 3 | MP0005365_abnormal_bile_salt | 4.06503066 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.87119934 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.82207934 |
| 6 | MP0001666_abnormal_nutrient_absorption | 2.99351829 |
| 7 | MP0003195_calcinosis | 2.99253782 |
| 8 | MP0003941_abnormal_skin_development | 2.83245965 |
| 9 | MP0003252_abnormal_bile_duct | 2.82910600 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.74430716 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.66635063 |
| 12 | MP0005083_abnormal_biliary_tract | 2.55177873 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.52400195 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.31768375 |
| 15 | MP0009840_abnormal_foam_cell | 2.29135493 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.27029676 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.24351665 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.16492048 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.10906414 |
| 20 | MP0010678_abnormal_skin_adnexa | 2.00161627 |
| 21 | MP0005220_abnormal_exocrine_pancreas | 1.89358715 |
| 22 | MP0006054_spinal_hemorrhage | 1.87561666 |
| 23 | MP0005332_abnormal_amino_acid | 1.84321408 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.81081771 |
| 25 | MP0009384_cardiac_valve_regurgitation | 1.78562514 |
| 26 | MP0005275_abnormal_skin_tensile | 1.78235539 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.78231700 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.77549119 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.73359099 |
| 30 | MP0004043_abnormal_pH_regulation | 1.65701882 |
| 31 | MP0005171_absent_coat_pigmentation | 1.62832440 |
| 32 | MP0000383_abnormal_hair_follicle | 1.61235925 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.60729099 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.60670209 |
| 35 | MP0003868_abnormal_feces_composition | 1.57858428 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.56575991 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.56103883 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.50162161 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.47919398 |
| 40 | MP0004130_abnormal_muscle_cell | 1.40575808 |
| 41 | MP0004264_abnormal_extraembryonic_tissu | 1.39314749 |
| 42 | MP0000609_abnormal_liver_physiology | 1.39231550 |
| 43 | MP0010368_abnormal_lymphatic_system | 1.38526156 |
| 44 | MP0004272_abnormal_basement_membrane | 1.37977916 |
| 45 | MP0001661_extended_life_span | 1.36020942 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.33720721 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.32870301 |
| 48 | MP0001299_abnormal_eye_distance/ | 1.30624851 |
| 49 | MP0003890_abnormal_embryonic-extraembry | 1.29200262 |
| 50 | MP0000427_abnormal_hair_cycle | 1.28970456 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.26652542 |
| 52 | MP0001944_abnormal_pancreas_morphology | 1.24930039 |
| 53 | MP0004484_altered_response_of | 1.24896673 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.24590407 |
| 55 | MP0002693_abnormal_pancreas_physiology | 1.23851109 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 1.23084027 |
| 57 | MP0003091_abnormal_cell_migration | 1.21463275 |
| 58 | MP0005023_abnormal_wound_healing | 1.21093998 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 1.20192561 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.20177926 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 1.18078416 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.16848361 |
| 63 | MP0002896_abnormal_bone_mineralization | 1.14897901 |
| 64 | MP0001756_abnormal_urination | 1.13325293 |
| 65 | MP0005330_cardiomyopathy | 1.13273410 |
| 66 | MP0005503_abnormal_tendon_morphology | 1.08948514 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.05451716 |
| 68 | MP0003283_abnormal_digestive_organ | 1.04613833 |
| 69 | MP0002254_reproductive_system_inflammat | 1.03846531 |
| 70 | MP0008004_abnormal_stomach_pH | 1.03783128 |
| 71 | MP0005409_darkened_coat_color | 1.03556207 |
| 72 | MP0002972_abnormal_cardiac_muscle | 1.03164252 |
| 73 | MP0001915_intracranial_hemorrhage | 1.02071857 |
| 74 | MP0004215_abnormal_myocardial_fiber | 1.00105650 |
| 75 | MP0005164_abnormal_response_to | 0.99317194 |
| 76 | MP0002060_abnormal_skin_morphology | 0.99155856 |
| 77 | MP0000003_abnormal_adipose_tissue | 0.99009323 |
| 78 | MP0002295_abnormal_pulmonary_circulatio | 0.98790336 |
| 79 | MP0004134_abnormal_chest_morphology | 0.98306634 |
| 80 | MP0005666_abnormal_adipose_tissue | 0.96761413 |
| 81 | MP0000639_abnormal_adrenal_gland | 0.95539252 |
| 82 | MP0003279_aneurysm | 0.94644675 |
| 83 | MP0005197_abnormal_uvea_morphology | 0.94589971 |
| 84 | MP0000751_myopathy | 0.94372244 |
| 85 | MP0000767_abnormal_smooth_muscle | 0.91715443 |
| 86 | MP0005595_abnormal_vascular_smooth | 0.91521746 |
| 87 | MP0000371_diluted_coat_color | 0.91150239 |
| 88 | MP0005248_abnormal_Harderian_gland | 0.90229381 |
| 89 | MP0000647_abnormal_sebaceous_gland | 0.89974713 |
| 90 | MP0009697_abnormal_copulation | 0.89711430 |
| 91 | MP0002234_abnormal_pharynx_morphology | 0.89430096 |
| 92 | MP0005375_adipose_tissue_phenotype | 0.88984551 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.86874007 |
| 94 | MP0003045_fibrosis | 0.86192567 |
| 95 | MP0004233_abnormal_muscle_weight | 0.85834245 |
| 96 | MP0002938_white_spotting | 0.84917311 |
| 97 | MP0000538_abnormal_urinary_bladder | 0.84764009 |
| 98 | MP0001544_abnormal_cardiovascular_syste | 0.84526931 |
| 99 | MP0005385_cardiovascular_system_phenoty | 0.84526931 |
| 100 | MP0004087_abnormal_muscle_fiber | 0.84261319 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.84158765 |
| 102 | MP0005670_abnormal_white_adipose | 0.84062619 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.84044517 |
| 104 | MP0002108_abnormal_muscle_morphology | 0.83745508 |
| 105 | MP0000750_abnormal_muscle_regeneration | 0.83434049 |
| 106 | MP0006138_congestive_heart_failure | 0.83100176 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.82912200 |
| 108 | MP0008775_abnormal_heart_ventricle | 0.82353015 |
| 109 | MP0005395_other_phenotype | 0.82028810 |
| 110 | MP0001879_abnormal_lymphatic_vessel | 0.80623196 |
| 111 | MP0002796_impaired_skin_barrier | 0.80233497 |
| 112 | MP0002160_abnormal_reproductive_system | 0.79973621 |
| 113 | MP0005165_increased_susceptibility_to | 0.79103533 |
| 114 | MP0010630_abnormal_cardiac_muscle | 0.78760807 |
| 115 | MP0003937_abnormal_limbs/digits/tail_de | 0.78679342 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.78005573 |
| 117 | MP0002269_muscular_atrophy | 0.77112393 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.76768534 |
| 119 | MP0000749_muscle_degeneration | 0.76022220 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.75667923 |
| 121 | MP0000534_abnormal_ureter_morphology | 0.75454628 |
| 122 | MP0005620_abnormal_muscle_contractility | 0.75446868 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74714576 |
| 124 | MP0005408_hypopigmentation | 0.74129360 |
| 125 | MP0000462_abnormal_digestive_system | 0.73970886 |
| 126 | MP0000598_abnormal_liver_morphology | 0.73380879 |
| 127 | MP0000604_amyloidosis | 0.72628206 |
| 128 | MP0001958_emphysema | 0.71512117 |
| 129 | MP0002928_abnormal_bile_duct | 0.69689791 |
| 130 | MP0002115_abnormal_skeleton_extremities | 0.69286410 |
| 131 | MP0002971_abnormal_brown_adipose | 0.68796497 |
| 132 | MP0001324_abnormal_eye_pigmentation | 0.67219986 |
| 133 | MP0003186_abnormal_redox_activity | 0.67060247 |
| 134 | MP0009642_abnormal_blood_homeostasis | 0.66022164 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.64898315 |
| 136 | MP0005334_abnormal_fat_pad | 0.64370325 |
| 137 | MP0000516_abnormal_urinary_system | 0.63725795 |
| 138 | MP0005367_renal/urinary_system_phenotyp | 0.63725795 |
| 139 | MP0005448_abnormal_energy_balance | 0.63464235 |
| 140 | MP0002168_other_aberrant_phenotype | 0.63134363 |
| 141 | MP0003122_maternal_imprinting | 0.62935386 |
| 142 | MP0005508_abnormal_skeleton_morphology | 0.62847495 |
| 143 | MP0006036_abnormal_mitochondrial_physio | 0.62061839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.30742169 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.24134075 |
| 3 | Ketoacidosis (HP:0001993) | 4.19272145 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.15874942 |
| 5 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.98096026 |
| 6 | Xanthomatosis (HP:0000991) | 3.95993384 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 3.95267416 |
| 8 | Hypoglycemic seizures (HP:0002173) | 3.85953759 |
| 9 | Ketosis (HP:0001946) | 3.75285675 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.73243161 |
| 11 | Mitral stenosis (HP:0001718) | 3.54333670 |
| 12 | Abnormality of the intrinsic pathway (HP:0010989) | 3.44506665 |
| 13 | Hyperglycemia (HP:0003074) | 3.36884520 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.33874092 |
| 15 | Aortic dissection (HP:0002647) | 3.31856864 |
| 16 | Aortic aneurysm (HP:0004942) | 3.31245421 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.25807524 |
| 18 | Symptomatic seizures (HP:0011145) | 3.17270267 |
| 19 | Vascular tortuosity (HP:0004948) | 3.12378506 |
| 20 | Arterial tortuosity (HP:0005116) | 3.06427107 |
| 21 | Generalized aminoaciduria (HP:0002909) | 3.04372657 |
| 22 | Fat malabsorption (HP:0002630) | 3.03984540 |
| 23 | Late onset (HP:0003584) | 3.03917602 |
| 24 | Follicular hyperkeratosis (HP:0007502) | 3.03696525 |
| 25 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.96015923 |
| 26 | Hyperlipoproteinemia (HP:0010980) | 2.93747526 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 2.93112807 |
| 28 | Gout (HP:0001997) | 2.89369067 |
| 29 | Hypobetalipoproteinemia (HP:0003563) | 2.85138121 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 2.84705737 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 2.83841118 |
| 32 | Skin nodule (HP:0200036) | 2.83510494 |
| 33 | Hyperammonemia (HP:0001987) | 2.82380905 |
| 34 | Hypolipoproteinemia (HP:0010981) | 2.78992720 |
| 35 | Myoglobinuria (HP:0002913) | 2.77837813 |
| 36 | Complement deficiency (HP:0004431) | 2.75530544 |
| 37 | Hyperglycinuria (HP:0003108) | 2.75153331 |
| 38 | Epidermoid cyst (HP:0200040) | 2.72348123 |
| 39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.70934205 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67349735 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 2.66541586 |
| 42 | Tetraparesis (HP:0002273) | 2.61658566 |
| 43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.58835732 |
| 44 | Protuberant abdomen (HP:0001538) | 2.54475715 |
| 45 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.51326219 |
| 46 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.51326219 |
| 47 | Abnormality of glycine metabolism (HP:0010895) | 2.46080009 |
| 48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.46080009 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.44801940 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.44801940 |
| 51 | Ventricular tachycardia (HP:0004756) | 2.41199947 |
| 52 | Ovoid vertebral bodies (HP:0003300) | 2.36637438 |
| 53 | Decreased circulating renin level (HP:0003351) | 2.36598662 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.33729904 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33729904 |
| 56 | Hyperglycinemia (HP:0002154) | 2.33661976 |
| 57 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31426968 |
| 58 | Osteolytic defects of the hand bones (HP:0009699) | 2.31426968 |
| 59 | Abnormality of carpal bone ossification (HP:0006257) | 2.30627207 |
| 60 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.30388462 |
| 61 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.30350964 |
| 62 | Flat acetabular roof (HP:0003180) | 2.29319084 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.29182554 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.29182554 |
| 65 | Asymmetric septal hypertrophy (HP:0001670) | 2.28908686 |
| 66 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.26258198 |
| 67 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.25169881 |
| 68 | Atrophic scars (HP:0001075) | 2.24257254 |
| 69 | Palpitations (HP:0001962) | 2.22005172 |
| 70 | Popliteal pterygium (HP:0009756) | 2.21731603 |
| 71 | Abdominal distention (HP:0003270) | 2.21427231 |
| 72 | Soft skin (HP:0000977) | 2.20048785 |
| 73 | Steatorrhea (HP:0002570) | 2.19990111 |
| 74 | Sudden death (HP:0001699) | 2.19888422 |
| 75 | Abnormal cartilage morphology (HP:0002763) | 2.19689471 |
| 76 | Hyporeflexia of lower limbs (HP:0002600) | 2.19530249 |
| 77 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17379420 |
| 78 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17379420 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17379420 |
| 80 | Papillary thyroid carcinoma (HP:0002895) | 2.14444963 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.11604764 |
| 82 | Hypothermia (HP:0002045) | 2.09640036 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.09557838 |
| 84 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.09067258 |
| 85 | Vascular calcification (HP:0004934) | 2.07646748 |
| 86 | Neonatal short-limb short stature (HP:0008921) | 2.04367592 |
| 87 | Abnormality of complement system (HP:0005339) | 2.04220098 |
| 88 | Hepatocellular carcinoma (HP:0001402) | 2.03802031 |
| 89 | Myocardial infarction (HP:0001658) | 2.03635216 |
| 90 | Wormian bones (HP:0002645) | 2.02938154 |
| 91 | Curly hair (HP:0002212) | 1.99762677 |
| 92 | Syncope (HP:0001279) | 1.99685181 |
| 93 | Absent frontal sinuses (HP:0002688) | 1.99363041 |
| 94 | Hematochezia (HP:0002573) | 1.99357049 |
| 95 | Esophageal varix (HP:0002040) | 1.98641435 |
| 96 | Protrusio acetabuli (HP:0003179) | 1.97670869 |
| 97 | Limited hip movement (HP:0008800) | 1.97422047 |
| 98 | Striae distensae (HP:0001065) | 1.96201549 |
| 99 | Metabolic acidosis (HP:0001942) | 1.95881542 |
| 100 | Exercise-induced muscle cramps (HP:0003710) | 1.95407901 |
| 101 | Insulin resistance (HP:0000855) | 1.95395556 |
| 102 | Asymmetry of the thorax (HP:0001555) | 1.94950942 |
| 103 | Increased purine levels (HP:0004368) | 1.93975385 |
| 104 | Hyperuricemia (HP:0002149) | 1.93975385 |
| 105 | Premature rupture of membranes (HP:0001788) | 1.92411531 |
| 106 | Abnormal pancreas size (HP:0012094) | 1.91569284 |
| 107 | Abnormality of the acetabulum (HP:0003170) | 1.91267683 |
| 108 | Type 1 muscle fiber predominance (HP:0003803) | 1.91027120 |
| 109 | Vacuolated lymphocytes (HP:0001922) | 1.90293819 |
| 110 | Alopecia of scalp (HP:0002293) | 1.89892074 |
| 111 | Large for gestational age (HP:0001520) | 1.88010866 |
| 112 | Joint hemorrhage (HP:0005261) | 1.87758891 |
| 113 | Hypercholesterolemia (HP:0003124) | 1.87382907 |
| 114 | Abnormality of urine glucose concentration (HP:0011016) | 1.87348647 |
| 115 | Glycosuria (HP:0003076) | 1.87348647 |
| 116 | Proximal tubulopathy (HP:0000114) | 1.87243900 |
| 117 | Abnormality of nucleobase metabolism (HP:0010932) | 1.86006124 |
| 118 | Abnormality of methionine metabolism (HP:0010901) | 1.84947996 |
| 119 | Abnormal hand bone ossification (HP:0010660) | 1.84687676 |
| 120 | Hyperbilirubinemia (HP:0002904) | 1.82615227 |
| 121 | Submucous cleft hard palate (HP:0000176) | 1.82568322 |
| 122 | Abnormality of the calf musculature (HP:0001430) | 1.82243473 |
| 123 | Hyperaldosteronism (HP:0000859) | 1.82094799 |
| 124 | Malnutrition (HP:0004395) | 1.79812235 |
| 125 | Cervical subluxation (HP:0003308) | 1.79156883 |
| 126 | Abnormality of the wing of the ilium (HP:0011867) | 1.78355516 |
| 127 | Pancreatitis (HP:0001733) | 1.78218719 |
| 128 | Abnormal biliary tract morphology (HP:0012440) | 1.77855819 |
| 129 | Abnormal foot bone ossification (HP:0010675) | 1.76993041 |
| 130 | Aneurysm (HP:0002617) | 1.75514344 |
| 131 | Increased connective tissue (HP:0009025) | 1.74192332 |
| 132 | Metaphyseal dysplasia (HP:0100255) | 1.74120244 |
| 133 | Abnormal tarsal ossification (HP:0008369) | 1.72909900 |
| 134 | Back pain (HP:0003418) | 1.72557220 |
| 135 | Abnormality of the ischium (HP:0003174) | 1.72522378 |
| 136 | Coarse hair (HP:0002208) | 1.71719987 |
| 137 | Hypoplastic ischia (HP:0003175) | 1.70308920 |
| 138 | Abnormal ossification of hand bones (HP:0005921) | 1.70275286 |
| 139 | Knee flexion contracture (HP:0006380) | 1.70038766 |
| 140 | Dilated cardiomyopathy (HP:0001644) | 1.68547317 |
| 141 | Abnormal gallbladder morphology (HP:0012437) | 1.68412142 |
| 142 | Tubular atrophy (HP:0000092) | 1.67413402 |
| 143 | Overgrowth (HP:0001548) | 1.66886840 |
| 144 | Short nail (HP:0001799) | 1.66682840 |
| 145 | Acanthocytosis (HP:0001927) | 1.65741426 |
| 146 | Abnormality of secondary sexual hair (HP:0009888) | 1.64332477 |
| 147 | Abnormality of the axillary hair (HP:0100134) | 1.64332477 |
| 148 | Ankle contracture (HP:0006466) | 1.64285134 |
| 149 | Abnormality of the renal cortex (HP:0011035) | 1.63160118 |
| 150 | Round ear (HP:0100830) | 1.62916549 |
| 151 | Abnormality of the nasal septum (HP:0000419) | 1.60623683 |
| 152 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.60097053 |
| 153 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.60033818 |
| 154 | Aplasia of the musculature (HP:0100854) | 1.59726680 |
| 155 | Vertebral compression fractures (HP:0002953) | 1.59131528 |
| 156 | Nemaline bodies (HP:0003798) | 1.58817194 |
| 157 | Spondylolisthesis (HP:0003302) | 1.58222893 |
| 158 | Thyroid carcinoma (HP:0002890) | 1.55736407 |
| 159 | Thickened calvaria (HP:0002684) | 1.55515200 |
| 160 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.55062389 |
| 161 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.54998156 |
| 162 | Congenital sensorineural hearing impairment (HP:0008527) | 1.54117607 |
| 163 | Pulmonic stenosis (HP:0001642) | 1.53560620 |
| 164 | Disproportionate short-trunk short stature (HP:0003521) | 1.53455211 |
| 165 | Mitral valve prolapse (HP:0001634) | 1.53331271 |
| 166 | Potter facies (HP:0002009) | 1.52703422 |
| 167 | Facial shape deformation (HP:0011334) | 1.52703422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.91619119 |
| 2 | INSRR | 3.82431178 |
| 3 | BCKDK | 3.75923952 |
| 4 | TRIB3 | 3.29711485 |
| 5 | FRK | 2.93872345 |
| 6 | PKN2 | 2.65782845 |
| 7 | LATS1 | 2.62672057 |
| 8 | ACVR1B | 2.48666043 |
| 9 | STK39 | 2.32487071 |
| 10 | TTN | 2.22231067 |
| 11 | SIK1 | 2.13418312 |
| 12 | TAOK3 | 2.07258242 |
| 13 | FLT3 | 2.02664808 |
| 14 | PTK6 | 1.93544827 |
| 15 | MAP3K2 | 1.91791425 |
| 16 | PDGFRA | 1.87375255 |
| 17 | LMTK2 | 1.86199659 |
| 18 | FGFR4 | 1.84648359 |
| 19 | MAP3K3 | 1.77758672 |
| 20 | BRSK2 | 1.76449107 |
| 21 | EPHA3 | 1.76132338 |
| 22 | MST1R | 1.72208128 |
| 23 | MET | 1.69324719 |
| 24 | BCR | 1.68949541 |
| 25 | FER | 1.65110239 |
| 26 | EIF2AK3 | 1.65011320 |
| 27 | MAPK15 | 1.52766310 |
| 28 | MYLK | 1.52741359 |
| 29 | WNK4 | 1.44573995 |
| 30 | PTK2 | 1.44278687 |
| 31 | WNK3 | 1.43868793 |
| 32 | EPHA2 | 1.35698784 |
| 33 | PIK3CG | 1.33482169 |
| 34 | IRAK3 | 1.33478512 |
| 35 | MAP2K2 | 1.29435810 |
| 36 | DDR2 | 1.25355444 |
| 37 | GRK1 | 1.24323831 |
| 38 | PIK3CA | 1.21248264 |
| 39 | LIMK1 | 1.21045292 |
| 40 | BMPR1B | 1.19988117 |
| 41 | EPHB1 | 1.19524315 |
| 42 | CASK | 1.19223229 |
| 43 | RIPK1 | 1.17346042 |
| 44 | PAK3 | 1.10916904 |
| 45 | PDK3 | 1.07296585 |
| 46 | PDK4 | 1.07296585 |
| 47 | TIE1 | 1.07047440 |
| 48 | TGFBR2 | 1.05725829 |
| 49 | PDK2 | 1.02338838 |
| 50 | EPHB2 | 1.01853762 |
| 51 | NLK | 1.01698707 |
| 52 | PASK | 1.01494357 |
| 53 | MAP2K1 | 1.01255140 |
| 54 | MAP4K2 | 1.01132075 |
| 55 | STK38L | 0.99171880 |
| 56 | PRKD3 | 0.97003314 |
| 57 | FGFR1 | 0.96985372 |
| 58 | FGFR2 | 0.96520758 |
| 59 | NEK9 | 0.96394694 |
| 60 | MAP3K12 | 0.95028616 |
| 61 | OXSR1 | 0.91038745 |
| 62 | MAP3K1 | 0.90334054 |
| 63 | PHKG1 | 0.87694764 |
| 64 | PHKG2 | 0.87694764 |
| 65 | ERBB4 | 0.87058073 |
| 66 | MAPKAPK3 | 0.86193760 |
| 67 | STK38 | 0.85788760 |
| 68 | OBSCN | 0.85498109 |
| 69 | STK24 | 0.82216673 |
| 70 | MAP3K4 | 0.81069678 |
| 71 | RET | 0.78419118 |
| 72 | MELK | 0.76296839 |
| 73 | PRKG2 | 0.75718590 |
| 74 | PRKD1 | 0.75126380 |
| 75 | SGK2 | 0.74967986 |
| 76 | TNIK | 0.73397066 |
| 77 | TRPM7 | 0.71005881 |
| 78 | JAK1 | 0.70381740 |
| 79 | NTRK1 | 0.69142658 |
| 80 | SGK3 | 0.68823192 |
| 81 | SCYL2 | 0.67470989 |
| 82 | PRKAA2 | 0.67081112 |
| 83 | ADRBK2 | 0.65084249 |
| 84 | ABL2 | 0.64390920 |
| 85 | DMPK | 0.63085677 |
| 86 | DYRK1B | 0.62664317 |
| 87 | TRIM28 | 0.62563821 |
| 88 | JAK2 | 0.62203868 |
| 89 | PLK2 | 0.61549703 |
| 90 | LRRK2 | 0.61155431 |
| 91 | PDGFRB | 0.61149291 |
| 92 | KDR | 0.60616071 |
| 93 | TYK2 | 0.60005339 |
| 94 | IRAK1 | 0.58890943 |
| 95 | CSNK1A1L | 0.58436657 |
| 96 | PRKAA1 | 0.57697179 |
| 97 | STK3 | 0.55748493 |
| 98 | GSK3A | 0.55404271 |
| 99 | MST4 | 0.54786219 |
| 100 | HIPK2 | 0.54052140 |
| 101 | FGFR3 | 0.52901186 |
| 102 | PAK4 | 0.52900710 |
| 103 | CAMK2D | 0.52532284 |
| 104 | GRK7 | 0.51638980 |
| 105 | TBK1 | 0.51615820 |
| 106 | MAP2K3 | 0.51050256 |
| 107 | TESK1 | 0.50034138 |
| 108 | PAK2 | 0.49240175 |
| 109 | PRKCE | 0.48738229 |
| 110 | PDPK1 | 0.47405481 |
| 111 | MUSK | 0.46940491 |
| 112 | BMPR2 | 0.46468081 |
| 113 | AKT3 | 0.46228579 |
| 114 | ERBB3 | 0.45824370 |
| 115 | NUAK1 | 0.44956669 |
| 116 | MTOR | 0.44268386 |
| 117 | TGFBR1 | 0.44159732 |
| 118 | CDC42BPA | 0.43965415 |
| 119 | IGF1R | 0.43847982 |
| 120 | MAPK11 | 0.43835371 |
| 121 | CSNK1G1 | 0.43112017 |
| 122 | PBK | 0.41594093 |
| 123 | PRKACG | 0.40578095 |
| 124 | MAP3K5 | 0.39918033 |
| 125 | RPS6KB1 | 0.39661593 |
| 126 | MAP3K7 | 0.39386226 |
| 127 | ROCK1 | 0.39327923 |
| 128 | ADRBK1 | 0.38921048 |
| 129 | MAP2K7 | 0.38867554 |
| 130 | KSR2 | 0.37667352 |
| 131 | PRKCH | 0.36579596 |
| 132 | ABL1 | 0.36246254 |
| 133 | EIF2AK1 | 0.35384227 |
| 134 | ERBB2 | 0.33176525 |
| 135 | PINK1 | 0.32752731 |
| 136 | CAMK1D | 0.32435898 |
| 137 | CAMKK2 | 0.32191205 |
| 138 | LATS2 | 0.31802961 |
| 139 | SGK223 | 0.31365690 |
| 140 | SGK494 | 0.31365690 |
| 141 | CDK6 | 0.30919233 |
| 142 | CHUK | 0.28089829 |
| 143 | CDK9 | 0.27713589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.42183667 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.81559687 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.73508771 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.70031222 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.54834645 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.42323854 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42247472 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19029872 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.17559009 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.12665727 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.04181189 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.02280546 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00268716 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93309909 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.91224677 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86537507 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.80364470 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77704573 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74504248 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66662435 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.66530609 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64083532 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.62689143 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.62010903 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.59711890 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57431504 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.52164690 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51487301 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.38815716 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36934688 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34263823 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30968516 |
| 33 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30429286 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.27736646 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27527790 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27399267 |
| 37 | Circadian rhythm_Homo sapiens_hsa04710 | 1.26920803 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26620172 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25508593 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23440430 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23216520 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20744072 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13109779 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11502217 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.06497465 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03522257 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01002688 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00477888 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00270533 |
| 50 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99218009 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.97856982 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95505317 |
| 53 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.93399122 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92667681 |
| 55 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.92635416 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.91313177 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90954859 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90499451 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88875335 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88023598 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87147689 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.87132308 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87073841 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.85803492 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80380802 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80149472 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77704850 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.77650104 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77385204 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.77283006 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76669645 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73892764 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73472739 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72771787 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70692073 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69443469 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68911764 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66852603 |
| 79 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.65826835 |
| 80 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62538095 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62040608 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61860630 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61565231 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.61009225 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58894255 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57356371 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56449923 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55920758 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55606132 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.54503088 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53190249 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48940471 |
| 93 | Melanoma_Homo sapiens_hsa05218 | 0.47892826 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45585887 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45530355 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45185362 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44901849 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44825636 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44509194 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44312131 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44133565 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43819224 |
| 103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42839386 |
| 104 | Insulin secretion_Homo sapiens_hsa04911 | 0.41981869 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41807285 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.41567948 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41013933 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40323342 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37342129 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.37178465 |
| 111 | Focal adhesion_Homo sapiens_hsa04510 | 0.36110522 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35501564 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34169321 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33507518 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33227601 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31122918 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30491574 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.29577885 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29437342 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.28622396 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28105271 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25738713 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.18826681 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16222473 |

